BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma Biotech Investing
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics Genetics Investing
VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101 Pharmaceutical Investing
Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology Biotech Investing
Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder Pharmaceutical Investing
Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis Pharmaceutical Investing
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Agrima Botanicals Cannabis Investing News
Xanthic Biopharma Inc. Receives Conditional Listing Approval from the Canadian Securities Exchange Cannabis Investing News
Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical solution Pharmaceutical Investing
Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma Pharmaceutical Investing
Q Biomed Inc. to Present at the Microcap Conference Taking Place April 9-10 at the Essex House in New York City Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness